BSECompany Update24 Aug 2026 · 24 Aug 2026, 07:23 pm

Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General ....

Eiko Lifesciences Ltd · 540204

✦ AI SummaryMgmt Change

Eiko Lifesciences Ltd has appointed Mr. Suraj Mahadev Gaikwad as Additional Director (Independent and Non-Executive) to hold the office up to the date of the ensuing Annual General Meeting of the Company, and thereafter as an Independent Director of the Company for a term of 5 (five) years, subject to the approval of shareholders.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Change in Management

Attachments (1)

📄

0df83913-8c11-4c57-b3df-37728878d12e.pdf

pdf

Download →
View document text
Date: 24th August, 2026 Corporate Services Department, BSE Limited, Phiroze Jeejeebhoy Towers, 1st Floor, Dalal Street, Fort, Mumbai - 400001. Scrip Code: 540204 Subject: Appointment of Additional Director (Independent and Non-Executive) Ref. : Outcome of the Board Meeting held on 24th August, 2026 Dear Sir/Madam, Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Monday, 24th August, 2026, Board, inter-alia, considered the following: 1. Approved appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General Meeting of the Company, and thereafter as an Independent Director of the Company for a term of 5 (five) years, subject to the approval of shareholders. Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 is attached herewith as Annexure A Please take the same on your records. For Eiko Lifesciences Limited Chintan Doshi Company Secretary and Compliance Officer Membership No: A 36190 Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com ANNEXURE – A Brief details of Appointment of Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as Additional Director (Independent and Non-Executive) Details as required under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 are annexed herewith. Sr. No Particular Details 1. Reason for change viz. Appointment of Mr. Suraj Mahadev Gaikwad as appointment, Resignation, Additional Independent and Non-Executive Director of removal, death or otherwise; the Company. 2. Date of Appointment 24th August, 2026 3. Term of Appointment Appointment of Mr. Suraj Mahadev Gaikwad as Additional Director (Independent and Non-Executive) of the Company to hold the office up to the date of the ensuing Annual General Meeting of the Company, and thereafter as an Independent Director of the Company for a term of 5 (five) years, subject to the approval of shareholders. 4. Qualification & brief profile (in case Mr. Suraj Mahadev Gaikwad is Commerce Graduate, of appointment) having more than 7 years of experience in accountancy and business Management. He brings extensive knowledge and diverse expertise to his professional endeavors, contributing meaningfully to financial operations and strategic planning. His strong background in the accountancy sector positions him as a valuable asset in supporting the organization’s strategic goals and enhancing overall operational efficiency and compliance structure. 5. Disclosure of relationship between None Directors (in case of appointment of Director) 6. Affirmation as required pursuant to Mr. Suraj Mahadev Gaikwad is not debarred from BSE Circular with ref. no. holding the office of director on account of any order LIST/COMP/14/2018-19 dated 20th of SEBI or any other such authority June, 2018. Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com